The largest database of trusted experimental protocols

57 protocols using paclitaxel

1

Paclitaxel Dissolution and Dilution

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paclitaxel (LC Laboratories) was initially dissolved in DMSO to get a solution of 0.01 M and subsequently diluted with MCF-7 growth medium to afford stock solutions with a drug concentration in the range of 0.1–50 µM. The concentration of DMSO reached 0.5% (w/v) in the 50 µM Paclitaxel solution and had no significant influence (P > 0.05) on cell viability compared to the untreated cells. In all the remaining working solutions, the concentration of DMSO never exceeded 0.1% (w/v).
+ Open protocol
+ Expand
2

Preparation of Paclitaxel-Albumin Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human serum albumin (lyophilized powder, ≥96%) was obtained from Sigma Aldrich (Oakville, ON, Canada). Paclitaxel (powder) was obtained from LC Laboratories (Woburn, MA, USA). Chloroform and all other chemicals were obtained from VWR International (Mississauga, ON, Canada).
+ Open protocol
+ Expand
3

Cell Cycle Analysis of Chemotherapeutics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at 1 × 105 per well of the 24-well plate and propagated in culture medium. Next day (after 18 hours), culture medium was replaced by the culture medium without drugs (control) or with 100 nM paclitaxel (PCT) or 30 μM adriamycin (LC Laboratories, Woburn, MA). Cells were harvested after 24 hours and fixed in 70% ethanol at 4°C overnight. Fixed cells were washed with phosphate-buffered saline, incubated with 40 μg/mL propidium iodide and 100 μg/mL RNase in phosphate-buffered saline, and cell cycle was analyzed using flow cytometer FACSVersa (Becton, Dickinson and Company, Franklin Lakes, NJ). CYP3A4 and AKR1C2 expression was monitored by qPCR and immunoblotting in parallel samples 48 hours after exposure to drugs.
+ Open protocol
+ Expand
4

Paclitaxel Delivery to Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 3

Delivery of paclitaxel to endothelial cells and tissue was studied in vitro using cells grown on Matrigel™ coated cell culture plates. Human coronary endothelial cells (HCAECs, Lonza, Walkersville, Md.) were cultured in EGM™-2MV growth media (Lonza, Walkersville, Md.). One day prior to paclitaxel transfer studies, cells were seed in 96 well BD Matrigel™ Matrix Thin-Layer cell culture plates at 20,000 cells per well in 0.2 mL of medium. Suspensions of paclitaxel (LC Laboratories, Woburn, Mass.) in water were prepared at 11 mg/ml paclitaxel and with PEI (Polysciences, Warrington, Pa.; MW=750 kDa) or PAMAM, ethylene diamine core, gen 4, dendrimer (Sigma, Milwaukee, Wis.; 14,214 Da) at 0.96 mg/mL (92:8 w/w ratio) or iopromide at 11 mg/mL (IOPR, 1:1 w/w ratio). Suspensions were sonicated briefly prior to use. Resulting suspensions (5 μL) were added to the cell culture plates and incubated for 3 or 10 minutes. Suspensions were also added to Matrigel™ coated plates with medium but without cells. After incubation plates were rinsed three times with phosphate buffered saline (200 μL per well) and then allowed to dry overnight. paclitaxel remaining in plates was dissolved in methanol (250 μL) and quantified by HPLC. The amount of transferred paclitaxel is shown in FIG. 3.

+ Open protocol
+ Expand
5

Paclitaxel Formulation for Intravenous Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paclitaxel (LC laboratories) was dissolved in 100 % ethanol. Equal volumes of Paclitaxel solution and cremophor (Sigma-Aldrich) were vigorously vortexed for 10 min. Ice-cold saline (80 % of the final volume) was added to freshly made Paclitaxel/cremophor solution immediately before injection. 30 mg/kg Paclitaxel in this solution was injected intravenously via tail vein at 3 times a week for 2 weeks. Survival time after treatment was 1 day.
+ Open protocol
+ Expand
6

Antiproliferative Effects of Kinase Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gefitinib (#G-4408), erlotinib (#E-4007), trametinib (#T-8123), crizotinib (#C-7900) and paclitaxel (#P-9600) were purchased from LC Laboratories (Woburn, MA, USA). Cisplatin (#479306) was purchased from Sigma Aldrich (St. Louis, MO, USA). 2D and 3D cultures were incubated in the presence of the drugs for 72 hours. Cell viability was determined using the commercially available alamarBlue® assay kit (Thermo Fisher Scientific, Madison, WI, USA). Apoptosis was analyzed using the Caspase-Glo® 3/7 assay multiplexed with the MultiTox-Fluor GF-AFC life stain (Promega, Madison, WI, USA). Luminescence and fluorescence intensities were measured using the Paradigm detection platform (Molecular Devices, Sunnyvale, CA, USA). Statistical analysis was done using the GraphPad Prism Software 7.03 (GraphPad Software Inc., La Jolla, CA, USA). For the in situ analyses of apoptosis in cocultures the cells were incubated in the presence of 50 nM Gefitinib or 20 nM crizotinib for 24 hours and processed for immunofluorescent microscopy using the cleaved caspase-3 antibody (Cell Signaling Technology, #9661) that specifically detects apoptotic cells.
+ Open protocol
+ Expand
7

Synergistic Effects of Valproic Acid and Paclitaxel

Check if the same lab product or an alternative is used in the 5 most similar protocols
Valproic acid (sodium salt, Sigma) was dissolved in sterile water to a stock concentration of 50 mg/ml and stored at −20 °C. Paclitaxel (Lc laboratories) was dissolved in absolute ethanol to 10 mM stock concentration and then diluted to the required concentrations, with complete cell culture medium. The final concentration of ethanol was no greater than 0.1%. This concentration of solvent had no effect on cell viability (measured by MTT assay). Dose–response studies were carried out in order to determine the suitable doses for further experiments. Cell culture treatments were assessed following two different schedules of administration: (i) single drug treatment was performed using 0.5–1–3–6–10–20 mM VPA or 0.01–0.1–1–10–20–50 μM PTX for 24, 48 and 72hs and (ii) dual drug treatment was performed treating cells with different concentrations of VPA for 24 h and then adding PTX at different concentrations for 48 h (Fig. S1).
Supplementary Fig. 1 can be found, in the online version, at doi:10.1016/j.toxrep.2014.05.005.

Drug administration schedule. (A) Single drug treatment and (B) combined drug treatment.

+ Open protocol
+ Expand
8

Evaluating Drug Combination Cytotoxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dasatinib, erlotinib and paclitaxel (LC Laboratories) were dissolved in water-free DMSO. For the determination of relative cell viability, 10 μM and 1 μM or serial dilutions of the three drugs were screened in quadruplicates. In brief, 8000 cells per well were seeded in 96-well plates 24 h prior to the addition of the individual compounds. For the co-treatment experiments, either siRNA transfection was carried out as described, or cells were pretreated with 100 nM ketoconazole for 2 h and then treated in the presence of ketoconazole. After incubation for 48 h or 7 days, cell viability was assessed using CellTiterBlue (Promega) following manufacturer’s instructions. Vehicle (DMSO) was used as negative control. Treatment with 20 μM staurosporine (LC Laboratories) was used as positive control. Responses were normalized to DMSO- and staurosporine- treated controls. Relative cell viability curves were plotted using Graph Pad Prism 6.0b software.
+ Open protocol
+ Expand
9

MTS Assay for Cell Proliferation Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HCC-1954, HCC-202, AU-565, SKBR-3, BT-474, and T47D cell lines (ATCC) were maintained in RPMI media (Corning) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin–streptomycin (Corning), whereas MDA-MB-468 and HCC-1419 (ATCC) were cultured in RPMI with 10% FBS, 1% penicillin–streptomycin (HyClone), 1% MEM non-essential amino acids (Gibco), and 100 μM sodium pyruvate (Gibco). The MDA-MB-231 cell line (ATCC) was cultured in DMEM (Corning) with 10% FBS and 1% penicillin–streptomycin (Corning). MTS assays were performed using the CellTiter 96 Aqueous One Solution Cell Proliferation Assay kit (Promega) as previously described45 . In brief, 10,000 cells/well were plated into a 96 well plate. Twenty-four hours later, the cells were treated with paclitaxel (LC Laboratories) for an additional 48 h. DMSO and the apoptosis-inducing pan-kinase inhibitor staurosporine (1 μM) were used as negative and positive controls, respectively. The absorbance at 490 nm (OD 490 nm) was normalized against DMSO.
+ Open protocol
+ Expand
10

Paclitaxel Modulates S. mansoni Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paclitaxel (LC Laboratories, Woburn, MA, USA) was reconstituted in PBS and a dose
of 25 mg/kg of mice was IP administered one day after intravenous augmentation
of the mice (challenge) with S. mansoni eggs. The dose was
selected as per the prior report.17 (link) Control mice were given PBS only. In the chronic hypoxia model,
Paclitaxel was IP administered at a dose of 25 mg/kg of mice, at days 1 and 8
.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!